These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27453703)

  • 21. The relative contribution of affinity and efficacy to agonist activity: organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors.
    Kenakin TP
    Br J Pharmacol; 1984 Jan; 81(1):131-41. PubMed ID: 6322891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decongestion effect and rebound swelling of the nasal mucosa during 4-week use of oxymetazoline.
    Graf P; Juto JE
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(3):157-60. PubMed ID: 7515487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of alternative spacer devices for delivery of aerosol therapy to children with asthma.
    Zar HJ; Liebenberg M; Weinberg EG; Binns HJ; Mann MD
    Ann Trop Paediatr; 1998 Jun; 18(2):75-9. PubMed ID: 9924566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cardiovascular effects and pharmacokinetics of intranasal tetracaine plus oxymetazoline: preliminary findings.
    Giannakopoulos H; Levin LM; Chou JC; Cacek AT; Hutcheson M; Secreto SA; Moore PA; Hersh EV
    J Am Dent Assoc; 2012 Aug; 143(8):872-80. PubMed ID: 22855901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasal tetracaine and oxymetazoline: a newly approved drug formulation that provides maxillary dental anesthesia without needles.
    Hersh EV; Saraghi M; Moore PA
    Curr Med Res Opin; 2016 Nov; 32(11):1919-1925. PubMed ID: 27646144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal application of the alpha2-adrenoceptor agonist BHT-920 produces decongestion in the cat.
    Mcleod RL; Erickson CH; Mingo GG; Hey JA
    Am J Rhinol; 2001; 15(6):407-15. PubMed ID: 11777250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of 3 intranasal mists for anesthetizing maxillary teeth in adults: A randomized, double-masked, multicenter phase 3 clinical trial.
    Ciancio SG; Marberger AD; Ayoub F; Garlapo DA; Pantera EA; Pantera CT; Al-Mubarak S; Sobieraj BD; He DY; Myneni SR
    J Am Dent Assoc; 2016 May; 147(5):339-347.e1. PubMed ID: 26892312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled clinical comparison of the BacT/ALERT FN and the standard anaerobic SN blood culture medium.
    Mirrett S; Petti CA; Woods CW; Magadia R; Weinstein MP; Reller LB
    J Clin Microbiol; 2004 Oct; 42(10):4581-5. PubMed ID: 15472312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of adrenergic alpha2-receptor agonists on urinary bladder contraction in conscious rats.
    Kontani H; Tsuji T; Kimura S
    Jpn J Pharmacol; 2000 Dec; 84(4):381-90. PubMed ID: 11202609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plastic bottles as spacers for a pressurized metered-dose inhaler: in vitro characteristics.
    Kissoon N; Teelucksingh S; Blake KV; Kesser B; Murphy SP; Geller D
    West Indian Med J; 2001 Sep; 50(3):189-93. PubMed ID: 11769021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Premedication Methods in Nasal Endoscopy: A Prospective, Randomized, Double-Blind Study.
    Şahin Mİ; Kökoğlu K; Güleç Ş; Ketenci İ; Ünlü Y
    Clin Exp Otorhinolaryngol; 2017 Jun; 10(2):158-163. PubMed ID: 27459198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothalamic alpha 2A-adrenoceptors stimulate growth hormone release in the rat.
    Makara GB; Kiem DT; Vizi ES
    Eur J Pharmacol; 1995 Dec; 287(1):43-8. PubMed ID: 8666024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation of the alpha-adrenergic inhibitory effects on glucagon- and secretin-stimulated bile volume and on cyclic adenosine monophosphate production in the isolated perfused rat liver.
    Yamatani K; Sato N; Takahashi K; Hara M; Sasaki H
    Endocrinology; 1985 May; 116(5):1694-8. PubMed ID: 2859188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzalkonium chloride in nasal decongestive sprays has a long-lasting adverse effect on the nasal mucosa of healthy volunteers.
    Hallén H; Graf P
    Clin Exp Allergy; 1995 May; 25(5):401-5. PubMed ID: 7553242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is nasal steroid spray bottle contamination a potential issue in chronic rhinosinusitis?
    Tan NC; Drilling AJ; Jardeleza C; Wormald PJ
    J Laryngol Otol; 2014 Jan; 128 Suppl 1():S28-33. PubMed ID: 23722019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The nasal airways response in normal subjects to oxymetazoline spray: randomized double-blind placebo-controlled trial.
    Bickford L; Shakib S; Taverner D
    Br J Clin Pharmacol; 1999 Jul; 48(1):53-6. PubMed ID: 10383560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre- and postsynaptic mechanisms in the clonidine- and oxymetazoline-induced inhibition of gastric motility in the rat.
    Zádori ZS; Shujaa N; Fülöp K; Dunkel P; Gyires K
    Neurochem Int; 2007 Oct; 51(5):297-305. PubMed ID: 17664022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.
    Watanabe H; Foo TH; Djazaeri B; Duncombe P; Mackay IS; Durham SR
    Rhinology; 2003 Sep; 41(3):167-74. PubMed ID: 14579657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of the alpha-adrenoceptor agonist oxymetazoline with serotonin 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors.
    Schoeffter P; Hoyer D
    Eur J Pharmacol; 1991 Apr; 196(2):213-6. PubMed ID: 1678720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxymetazoline enhances epidermal- and platelet-derived growth factor-induced DNA synthesis.
    Nickenig G; Ko Y; Nettekoven W; Appenheimer M; Schiermeyer B; Vetter H; Sachinidis A
    Atherosclerosis; 1994 Jan; 105(1):71-7. PubMed ID: 7908802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.